Related Experiment Video

Updated: Aug 2, 2026

Murine Fetal Echocardiography
08:04

Murine Fetal Echocardiography

Published on: February 15, 2013

Intracavitary cardiac hydatid cyst

A Abid1, S Ben Omrane, K Kaouel

  • 1Department of Cardiovascular Surgery, La Rabta Hospital, 1007 Jabbari, Tunis, Tunisia.

Cardiovascular Surgery (London, England)
|November 25, 2003
PubMed

Insights

Intracavitary cardiac hydatid cysts require surgical intervention, often necessitating cardiopulmonary bypass. While surgery yields satisfactory short-term outcomes, recurrence of pulmonary cysts is common, highlighting the need for post-operative medical treatment with Albendazole.

Area of Science:

  • Cardiology
  • Parasitology
  • Thoracic Surgery

Background:

  • Hydatid cysts, caused by Echinococcus granulosus, can affect various organs, including the heart.
  • Intracavitary cardiac involvement presents unique diagnostic and management challenges.

Purpose of the Study:

  • To determine diagnostic methods, surgical management, and prognosis for patients with intracavitary cardiac hydatid cysts.
  • To evaluate the outcomes of surgical intervention and medical treatment in a series of patients.

Main Methods:

  • Retrospective case series of seven patients with intracavitary cardiac hydatid cysts.
  • Diagnosis aided by coexisting pulmonary hydatid locations.
  • Surgical management involved cardiopulmonary bypass, aortic cross-clamping, and cardioplegia.

Main Results:

  • All cysts were located in the right cardiac chambers.
  • Postoperative recovery was satisfactory for all patients.
  • Pulmonary cyst recurrence occurred in all patients after a mean of 42 months; medical treatment (Albendazole) was initiated.
  • One late death occurred at 3 years due to chronic right heart failure.

Conclusions:

  • Intracavitary cardiac hydatid cysts should be suspected in patients with pulmonary or systemic embolization.
  • Early surgical treatment is crucial.
  • Post-operative medical management with Albendazole is essential to prevent recurrence.

More Related Videos

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

Transient Transduction of the Strobilated Forms of Echinococcus granulosus13:25

Transient Transduction of the Strobilated Forms of Echinococcus granulosus

Published on: September 16, 2022

Related Concept Videos

Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...